FDA approves Quill's tissue repair device:
This article was originally published in Clinica
The US FDA has approved for sale Quill Medical's barbed polydioxanone suture for closing wounds in dermal tissue. The product represents the first in a line of tissue repair devices being developed by the company, that enables sutures to "self-anchor" themselves in tissue without the surgeon having to perform a suture knot, said the Research Triangle Park, North Carolina-based firm. Quill Medical CE marked the product for sale in Europe in May.
You may also be interested in...
Revised bill released by the US Senate Finance Committee adjusts the manufacturer discount program in Medicare Part D and includes new provisions aimed at easing beneficiary cost sharing obligations.
Through a draft guidance, the US agency has established performance criteria for magnetic resonance coils, making the devices eligible for the standards-based Safety and Performance Based Pathway.
Singapore recalls trigger international reaction as metformin is added to growing list of chronic medications found to contain NDMA.